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Trends
EVs are secreted by most or all organ-
isms and are emerging as a ubiquitous
and functionally diverse type of host–
pathogen interaction.
EVs contain a diverse suite of mole-
cules including proteins, lipids, and
nucleic acids, some of which are
known to have immunomodulatory
properties.
Parasite-derived EVs can communi-
cate information and transfer genetic
material to host cells or other parasites.
Host-derived EVs can play a key role in
host defense and are candidates for
generating a vaccine against patho-
genic infection.
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Extracellular vesicles (EVs) have emerged as a ubiquitous mechanism for trans-
ferring information between cells and organisms across all three kingdoms of
life. In addition to their roles in normal physiology, vesicles also transport
molecules from pathogens to hosts and can spread antigens as well as infec-
tious agents. Although initially described in the host–pathogen context for their
functions in immune surveillance, vesicles enable multiple modes of communi-
cation by, and between, parasites. Here we review the literature demonstrating
that EVs are secreted by intracellular and extracellular eukaryotic parasites, as
well as their hosts, and detail the functional properties of these vesicles in
maturation, pathogenicity and survival. We further describe the prospects for
targeting or exploiting these complexes in therapeutic and vaccine strategies.
Host–Parasite Interactions: Do We Know it All?
More than 1 billion people worldwide are burdened by parasitic disease, includingmalaria [1] and
neglected tropical diseases such as leishmaniasis, Chagas disease and helminthiases (http://
whqlibdoc.who.int/hq/2012/WHO_HTM_NTD_2012.1_eng.pdf), with most prevailing in devel-
oping regions such as eastern Asia, sub-Saharan Africa, and the Americas [2]. The prospects for
drug resistance are alarming, with an increasing incidence in livestock that highlights a potential
threat to the human population through zoonotic transmission as well as having strong
economic and social implications [3]. There is a clear need for more efﬁcacious therapies,
which require an improved understanding of how these parasites adapt to, andmanipulate, their
host environment. Most parasites at some stage in their life cycle rely on the ability to communi-
cate with one another and with their hosts, but the mechanisms underpinning this communica-
tion are still coming to light. Research in this area has largely focused on the soluble proteins
secreted by parasites, many of which down-modulate the host immune response (reviewed in
[4,5]). For example, in the case of helminths, the egg stage of Schistosoma mansoni secretes an
omega-1 glycoprotein, demonstrated in several studies to promote type 2 helper (Th2) skewing
of dendritic cells (DCs) and T cells during infection [6,7]. The immunomodulatory lipoprotein
antigen B is secreted by Echinococcus granulosus and facilitates Th2 polarization and limits
migration of neutrophils to the site of infection [8]. The ES-62 protein from Acanthocheilonema
viteae has potent anti-inﬂammatory properties on mast cells [9]. Protozoan parasites similarly
secrete a range of immunomodulatory molecules; for example, Trypanosoma cruzimucins have
been associated with suppression of active T cell immune responses by inducing arrest in the
cell cycle [10]. Secreted parasite proteins have also been proposed to be involved in metabolic
adaptation to the host environment [11] and tissue invasion, where proteases play a major role
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products that provide a previously unrecognized mechanism to package and protect a set of
parasite cargo for uptake and integration into other cells. EVs are known to play a role in
communication and genetic exchange between microbes [13]. The functional niches in which
EVs operate in eukaryotic parasites and other pathogens are still emerging and are summarized
in Table 1.Table 1. Proposed Functions of Pathogen or Host-Derived Exosomes during Infectiona
Pathogen EV origin Host or
parasite?
EV target Functional response Effector mechanism Refs
Protozoa
Leishmania
amazonensis
Macrophages
exposed to
promastigotes
Host Monocytes and/or
macrophages
Promotion of Th1
responses for parasite
elimination
Naïve macrophages are
primed to release IL-12, IL-1b,
and TNF
[46]
Leishmania
donovani
Promastigotes Parasite Monocytes and/or
macrophages
Invasion and persistence
within host cells and
delivery of virulence
factors
Leishmania EF-1/ and GP63
activate host PTPs in
monocytes responding to
IFNg. GP63 can also inﬂuence
exosome cargo selection and
inhibit host miRNA processing.
[35–37,39,
40,42]
Parasite Immune cells, including
macrophages
Induction of Leishmania
peptide-carrying exosomes
from monocytes
Overall increase in IL-8
secretion by macrophages,
which promotes neutrophil
recruitment. Induces release of
IL-10 in human monocytes
while suppressing release of
TNF.
[35–37]
Leishmania
major
Promastigotes Parasite Monocytes/macrophages Invasion and persistence
within host cells and
delivery of virulence factors
Leishmania EF-1/ and GP63
activate host PTPs in
monocytes responding to
IFNg.
[39,41]
Parasite Immune cells, including
macrophages and T cells
Increased disease
exacerbation and Th2
polarization in vivo
Increase in the number of IL-4-
producing CD4+ T cells/
decrease in the number of
IFNg-producing CD4+ T cells
[37]
Leishmania
mexicana
Macrophages
exposed to
promastigotes
Parasite Macrophages Immunomodulation of host
signaling events promoting
parasite survival
Upregulation of Adora2a by
parasite-derived GP63
contained within host
exosomes
[40]
Plasmodium
berghei
Infected
erythrocytes
Host Macrophages Activate systemic
inﬂammation and T cell
priming
Via MyD88/TLR4 pathway and
CD40/CD40L interactions
[77]
Plasmodium
falciparum
Infected
erythrocytes
Parasite Monocytes and
macrophages
Transfer of parasite
material and parasite
dissemination
Innate cell activation. Cytokine
induction in macrophages (IL-6,
IL-12, IL-1b, and IL-10) in a
dose-dependent manner.
[49]
Parasite Infected erythrocytes Commitment of asexual
parasites to gametocytes
Transfer of genetic information
between parasites and
budding of EVs via PfPTP2
[49,50]
Plasmodium
vivax
Platelets,
erythrocytes,
leukocytes
Host Human immune cells,
erythrocytes, endothelial
cells
Higher acute fever and
greater duration of malaria
symptoms in human
patients
Unknown mechanism [78]
Trichomonas
vaginalis
Mature parasites Parasite Ectocervical cells Limit neutrophil migration to
site of infection
Parasite-derived exosomes
downregulate IL-8 secretion in
ectocervical cells
[54]
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Table 1. (continued)
Pathogen EV origin Host or
parasite?
EV target Functional response Effector mechanism Refs
Parasite Weakly adherent strains of
the parasite
Promote adherence of
weakly adherent strains
and increase their virulence
Unknown mechanism [54]
Trypanosoma
brucei
Procyclic forms of
the parasite
(pathogenic in
bloodstream)
Parasite Host cells Improved entry into host
cells, enhanced parasite
survival
Abundance of parasite-derived
proteases (e.g., oligopeptidase
B) favors parasite invasion
[51–53]
Trypanosoma
cruzi
Trypomastigotes Parasite CD4+ T cells and
macrophages
Th2 polarization leading to
parasite dissemination and
enhanced parasite survival
Increase in IL-4 and IL-10
secretion and reduction in
iNOS expression in CD4+ T
cells and macrophages
[34]
Infected
lymphocytes,
monocytes and
erythrocytes
Parasite Recipient immune cells and
monocyte-derived
complement factors
Parasite invasion of host
cells and inhibition of
complement-induced
parasite elimination
Plasma membrane-derived
vesicles containing surface
TGF-b, which promotes entry
into host cells
[47,48]
Fungi
Cryptococcus
neoformans
Exosomes secreted
during the fungal
cell phase
Pathogen Host cells – unknown Promote colonization of
infected tissues
Release virulence factors –
glucosylceramide and GXM
[72]
Pathogen Macrophages Stimulate fungal killing Enhanced IL-10 and TGF-b
secretion and increased
nitric oxide production by
macrophages
[75]
Malassezia
sympodialis
Yeast – skin-living
ﬂora component
Pathogen PBMCs Exacerbation of atopic
dermatitis
Promote IL-4 and TNF
secretion from PBMCs
[74]
Paracoccidioides
brasiliensis
Yeast phase
exosomes
Pathogen Immune cells Potential to skew to a
suppressive Th2 response
Enriched in /-Gal, which may
bind host lectins potentially
improving infectivity by fungi
[69]
Helminths
Heligmosomoides
polygyrus
Intestinal tract of
adult nematode
Parasite Intestinal epithelial cells of
the host
Suppress classical
inﬂammation and danger
responses, promoting
parasite survival
Suppression of host targets
including IL-33R and DUSP1
[59]
Schistosoma
japonicum
Adult worms Parasite Macrophages Polarization of host
macrophages to M1
phenotype
Unknown mechanism [58]
aDetails in each column (from left to right) describe: the parasite species, the life stage and/or cellular origin of the EV, the proposed beneﬁciary (host or parasite), the
proposed target and functional outcome, the mechanistic data in support of this function, and the primary literature reference.Exosomes and Other Extracellular Vesicles: Origins and Functions
In mammalian systems EVs represent a mechanism of cell-to-cell communication through the
direct stimulation of cells by receptor-mediated contact and/or through the transfer of genetic
material, proteins, and lipids. Several distinct types of EV have been described, including those
derived from the endocytic pathway, exosomes, versus those derived from shedding of the
plasma membrane. We refer to the latter as microvesicles but note that these have been called
by many names in the literature, including ectosomes, plasma membrane-derived vesicles, and
microparticles [14]. Exosomes are endocytic vesicles approximately 40–100 nm in size that are
released from most cell types [15]. Their biogenesis is initiated by inward budding of multi-
vesicular endosomes (Figure 1). Consequently, exosomes express markers of their parent cells,
but are also speciﬁcally enriched in other molecules associated with their biogenesis or that areTrends in Parasitology, October , Vol. 31, No. 10 479
Figure 1. The Biogenesis and Transfer of Different Extracellular Vesicles (EVs). (A) Early endosome formation
within the parent cell, surrounded by a range of different bioactive molecules [e.g., nucleic acids, proteins, lipids (denoted by
different colors and/or shapes)]. (B) On development into a late endosome, inward budding allows capture of some of the
host cell cytosolic contents in intraluminal vesicles (ILVs). The late endosome is also referred to as a multivesicular body
(MVB). (C) Some mature MVBs fuse with the hydrolytic lysosome, where the vesicle cargo is subsequently degraded.
(D) MVBs can also fuse directly with the plasma membrane, releasing their ILVs, now known as exosomes, into the
extracellular space. (E) Release of exosomes into the extracellular environment. (F) Other microvesicles are released into the
extracellular space following direct budding from the host cell plasma membrane. There are at least three mechanisms by
which EVs interact with recipient cells: (G) direct fusion with the plasma membrane of the recipient cell; (H) receptor-
mediated endocytosis following receptor–ligand interactions between EVs and the recipient cell; and (I) signaling via direct
interactions of receptor and ligand on the recipient cell surface.selectively packaged into them; for example, by the endosomal sorting complexes required for
transport (ESCRT) pathway (reviewed in [16]). Microvesicles can be difﬁcult to distinguish from
exosomes, but are generally up to 1 mm and bud from the plasma membrane, incorporating
certain lipids, surface proteins, and other molecules before ﬁssion [17]. As reports in the literature
do not always identify vesicular origin, here we refer to parasite exosomes or ‘exosome-like
vesicles’ if they have been described as such in the primary literature or parasite microvesicles if
they are suggested to derive from the plasma membrane, or ‘EVs’ if the origin is unclear.
In recent years, the literature surrounding EV function has exploded as their ubiquity in many
biological and disease contexts has been realized [18]. Historically, these were ﬁrst identiﬁed in
reticulocytes as a mechanism to release transferrin receptors during maturation [19,20] and then
became of interest to immunologists as they contain MHCs and can present antigens [21].
However, following the report that functional mRNAs and miRNAs are transferred between mast
cells via exosomes [22], there was further momentum in studying EVs as a mechanism of cell–
cell communication. In this context, they have been shown to have various functions in immune
cell activation and suppression [23,24] and are also proposed to play a role in disease
development and tissue homeostasis, [25]. An ever-expanding literature has also demonstrated
various roles of EVs in diseases including cancer, since tumors also secrete these vesicles with480 Trends in Parasitology, October , Vol. 31, No. 10
oncogenes [26], such as those seen in gastrointestinal stromal tumor cell lines [27]. Exosomes
and other EVs are now part of larger clinical initiatives to test their properties in drug delivery, their
use as diagnostic biomarkers, and their potential as therapeutics. While most of this work has
focused on oncology [28,29], these vesicles also have exciting implications across a range of
infectious diseases [30]. Here we detail the recent literature describing their roles in eukaryotic
parasite infection, focusing on the communicative relationship between parasites and hosts.
Furthermore we highlight the importance of EVs in the future identiﬁcation of novel therapeutic
targets and the development of vaccine strategies.
Intracellular Protozoan Parasites: Host Manipulation by EVs
Several protozoan parasites have been shown to release exosomes and/or microvesicles,
including Leishmania species [31] and T. cruzi [32–34], the parasites that cause human
leishmaniasis and Chagas disease, respectively. Seminal reports showed that promastigote
and amastigote forms of Leishmania donovani and Leishmania major can release exosomes that
are detected in host cells and selectively induce IL-8 secretion from macrophages [35,36]
(Figure 2A). The subsequent chemokinetic recruitment of neutrophils has been proposed as a
‘Trojan horse’ effect, whereby Leishmania can invade these cells and gain access to macro-
phages on phagocytosis of the infected neutrophils [37,38]. Leishmania exosomes have also
been shown to induce the release of the immunosuppressive cytokine IL-10 and inhibit theFigure 2. Schematic Representation of the Different Functions of Parasitic Extracellular Vesicles (EVs). (A)
Leishmania spp. promastigotes release exosomes, which can modulate immune properties of monocytes, shown by an
increase in the production of IL-8 and IL-10 and a decrease in tumor necrosis factor (TNF) and nitric oxide [35–37]. Infected
monocytes also release exosomes that have immunomodulatory properties in recipient cells (indicated by broken line), such
as the induction of protein tyrosine phosphatases (PTPs) and changes in gene expression [39,41]. (B) Trypanosoma cruzi
trypomastigote-shed microvesicles can induce type 2 helper (Th2) polarization [seen by an increase in IL-4 and IL-10 and a
decrease in inducible nitric oxide synthase (iNOS)] and invasion of cardiac tissue (indicated by broken line) [34]. Infected
erythrocytes and lymphocytes release microvesicles containing surface transforming growth factor beta (TGF-b) [47]. (C)
The extracellular protozoan Trichomonas vaginalis secretes exosomes, which can promote better adherence of weaker
strains to ectocervical cells [54]. (D) Adult Heligmosomoides polygyrus worms secrete exosomes as part of their excretory–
secretory product in the lumen of the small intestine. These are potentially taken up by intestinal epithelial cells, where they
modulate gene expression of themitogen-activated protein (MAP) kinase regulatory phosphatase gene dusp1 and the IL-33
receptor (ILRL1) and can have downstream suppressive effects on antiparasite type 2 responses [59].
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inﬂammatory cytokine tumor necrosis factor (TNF) in human monocyte-derived DCs in response
to interferon gamma (IFNg). Pretreatment of mice with exosomes derived from L. major and
L. donovani resulted in exacerbated infection and pathogenesis in vivo, associated with
enhanced IL-10 production and a skewed Th2 response, preventing parasite expulsion as a
type 1 response is normally required for clearance [37]. Speciﬁc components of Leishmania
exosome cargo have also been identiﬁed and shown to be involved in immunomodulation,
including elongation factor 1 alpha (EF-1/) and the membrane-bound metalloprotease GP63
[39]. These have both been associated with a depression in signalling events during a proin-
ﬂammatory IFNg response by monocytes (and potentially subsequent Th1 polarization) [36,40].
GP63 is also associated with numerous downstream modulatory effects during Leishmania
infection, including the modulation of inﬂammation by activating macrophage protein tyrosine
phosphatase (PTP) signaling. This metalloprotease has also been shown to impact protein
sorting into exosomes and to inhibit miRNA processing in host cells by targeting the endor-
ibonuclease DICER [39,41,42].
At least two types of EV have been identiﬁed from the infective (metacyclic trypomastigote) and
noninfective (epimastigote) forms of T. cruzi parasites; both forms release microvesicles from the
plasma membrane as well as exosomes presumed to derive from the endocytic pathway [32].
Following their initial identiﬁcation [43], these EVs were further shown to contain a cohort of
proteins associated with immune modulation and virulence and include the homolog to the
multifunctional metalloprotease GP63, described above [32]. Notably, following inoculation of
the parasite microvesicles and subsequent infection with T. cruzi, mice develop heightened
cardiac parasitism and increased inﬂammatory inﬁltrates associated with higher levels of IL-4
and IL-10 [34]. These cytokines induce the polarization of a Th2 response as well as lower levels
of inducible nitric oxide synthase (iNOS) in the tissue, suggesting that these microvesicles may
serve to promote parasite dissemination and enhance survival (Figure 2B). Acid phosphatases
involved in the adherence and infection of various trypanosome strains have also been shown to
be present in the microvesicles [44].
In addition to the direct secretion of exosomes and microvesicles by these parasites, both
Leishmania spp. and T. cruzi induce the release of exosomes from the cells that they infect. A
study of Leishmania mexicana-treated macrophages in vitro showed that exosomes released
from infected cells are capable of inducing phosphorylation of signaling proteins and signiﬁcantly
upregulating immune-related genes including adenosine receptor 2a (Adora2a) on macro-
phages [40]. Interestingly, Adora2a receptor activation on these cells by Escherichia coli, another
pathogen that drives type 1 immune responses, has been associated with increased IL-10 and
down-modulated TNF [45]. Conversely, a recent study suggests that exosomes from Leish-
mania amazonensis-infected macrophages can prime other naïve macrophages to initiate
antiparasitic Th1 responses through the release of the inﬂammatory cytokines IL-12, IL-1b,
and TNF [46]. T. cruzi also induces the release of microvesicles from infected host cells, including
lymphocytes and monocytes in vitro and erythrocytes in vivo. These microvesicles express
surface transforming growth factor beta (TGF-b), which has been shown to facilitate eukaryotic
cell invasion by the parasite and leads to maturation and continuation of the life cycle [47]. The
microvesicles also protect extracellular life cycle stages of T. cruzi, including epimastigotes from
the vector and trypomastigotes from ruptured cells, from complement-mediated attack, thus
facilitating parasite invasion of host cells [48]. More speciﬁcally, monocyte-derived microvesicles
develop a complex with the complement C3 convertase C4b2a on the parasite surface, limiting
the interaction with its substrate C3. The inhibition of this crucial step prevents complement-
mediated lysis, opsonization, and the release of anaphylatoxins, subsequently leading to
increased parasite survival [47]. In an analogous manner, erythrocytes infected with the malaria
parasite Plasmodium falciparum produce microvesicles that enhance dose-dependent secre-
tion of proinﬂammatory cytokines such as IL-1b, IL-6, and IL-12 from monocytes following482 Trends in Parasitology, October , Vol. 31, No. 10
phagocytosis [49]. In the context of infection, it has been hypothesized that these cytokines may
aid endothelial cell activation and erythrocyte sequestration. As with many immunomodulatory
mechanisms, however, it can be difﬁcult to distinguish whether vesicle secretion by host cells
during infection is controlled by the host and/or the parasite, as both may beneﬁt. This is
discussed further later in this review.
Interspecies Communication between Intracellular Protozoan Parasites
In addition to manipulation of the host immune response, EVs can also mediate intercellular
communication between parasites. It has been reported that microvesicles trafﬁc between P.
falciparum-infected erythrocytes and increase the commitment of asexual parasites to the
sexual stages, gametocytes, to promote transmission [49,50]. Furthermore, it is suggested
that EVs (described by Regev et al. as ‘exosome-like’ [50]) secreted by red blood cells following
infection with transgenic P. falciparum parasites can rescue parasitic growth by transferring DNA
encoding a drug resistance marker to other P. falciparum in infected cells under conditions of
drug selection. Thus, genetic material can be transferred between the infected erythrocytes via
EVs, and this may also contribute to the sexual development mentioned above. This pathway
has been shown to be dependent on trafﬁcking mechanisms that transport parasite-encoded
proteins to the host-erythrocyte membrane through membranous structures called Maurer's
clefts in infected erythrocytes [50].
This is one of the few examples to date of vesicle involvement in parasite-to-parasite communi-
cation (a further example is provided below in the case of the extracellular parasite Trichomonas
vaginalis). This is likely to represent a bias in the literature, which focuses largely on the
immunomodulatory properties of parasite secretion products. In the microbial context, it is well
established that secreted vesicles play a role in microbe–microbe communication and genetic
exchange (reviewed in [13]). Many gaps remain in our understanding of how different eukaryotic
parasites communicate with one another to regulate aspects of their life cycles, including
reproduction or commitment to transmission stages. It will be interesting to see whether this
is a functional niche occupied by EVs that extends beyond malaria parasites.
Extracellular Protozoan Parasites: Communication within Their Environment
An obvious function of EVs in extracellular pathogens is their ability to protect cargo and move
this into host cells. However, mechanistic aspects of this are not understood, including whether
and how there is speciﬁcity in the uptake by certain cell types, whether the parasite cargo is
recognized by the host immune system, and how communication is conducted between two
phylogenetically distant species. Among extracellular protozoan parasites, comparative analysis
of the secretome of Trypanosoma brucei subspecies, the causative agent of African sleeping
sickness, identiﬁed several exosome-associated proteins such as enolase, heat-shock protein
70, and the clathrin heavy chain. Different members of themetallopeptidase family are also found
in the secreted microvesicles and may serve as potential drug targets or even diagnostic
biomarkers during stages of African trypanosomiasis [51,52]. Complimentary studies on the
T. brucei secretome also demonstrate the presence of 50–100-nm microvesicles budding from
the plasma membrane of the infective parasite [53]. The parasitic protozoan T. vaginalis, which
can cause infertility through sexual transmission, has been shown to release functional exo-
somes that can play a role in both parasite-to-parasite and parasite-to-host communication [54].
Virulence products are present within the exosomes that are able to speciﬁcally downregulate IL-
8 secretion by ectocervical cells (potentially limiting neutrophil migration to prevent pathogen
clearance). Furthermore, preincubation with exosomes released from a more adherent strain of
the parasite, B7RC2, can induce better adherence of weaker strains, such the laboratory strain
G3, in a dose-dependent fashion, which is not seen in the converse scenario (Figure 2C). The
mechanisms underpinning these effects and the cargo within the exosomes involved are not yet
known.Trends in Parasitology, October , Vol. 31, No. 10 483
Extracellular Parasites: Interactions at the Cell-to-Parasite Interface
Helminth worms are ubiquitous pathogens of plants and animals that have coevolved with their
hosts for hundreds of millions of years and use sophisticatedmechanisms for manipulating them
[55]. It has only recently been demonstrated that these complex parasites also secrete exo-
somes, and potentially other classes of EV, into the environment that can be internalized by host
cells. Electron microscopy images of EVs derived from diverse helminths are shown in Figure 3,
including studies in the trematodes Fasciola hepatica and Echinostoma caproni, which release
EVs that can be detected on the tegumental surface. Marcilla et al. [56], showed that these EVs
are internalized by rat intestinal epithelial cells in vitro and contain protein homologs of proteins
found in mammalian exosomes. Notably, earlier work examining the glycocalyx of S. mansoni
cercariae demonstrated the potential presence of structures similar to multivesicular bodies
adjacent to the schistosomula tegument [57]. A recent study has detailed the presence of
exosome-like vesicles secreted by Schistosoma japonicum adults that were shown to induce
macrophage polarization to a M1 phenotype, thereby highlighting the potential immunomodu-
latory properties of Schistosoma-derived exosomes and their potential role during infection [58].
We recently demonstrated that the gastrointestinal nematode Heligmosomoides polygyrus
secretes exosomes that are internalized by host cells (Figure 2D). These are enriched in speciﬁc
proteins, including those associated with exosome biogenesis (e.g., alix, enolase, HSP70), as
well as many proteins of unknown function and contain miRNAs and other classes of noncoding
RNA [59]. The presence of an Argonaute protein and small RNAs within nematode exosomes
may suggest the existence of cross-species RNA interference, although the mechanism of this
remains unknown. Several of the H. polygyrus exosome-derived miRNAs have target sites in the
30 untranslated region (30UTR) of the mouse dusp1 gene, which encodes a mitogen-activated
protein (MAP) kinase regulatory phosphatase. We showed that transfection of three nematode-
derived miRNAs could suppress a luciferase reporter containing the 30UTR of DUSP1. Although
relatively little is known about this phosphatase in helminth infection, DUSP1/ macrophages
have previously been shown to have sustained IL-10 expression in the presence of helminth
cystatins [60]. IL-10 is an immunoregulatory cytokine that could prevent an antiparasitic or
inﬂammatory response and promote parasite longevity within the host [61,62]. We furtherFigure 3. Electron Micrographs Demonstrating Exosome-Like Vesicles Derived from Extracellular Helminths.
(A) Presence of exosome-like vesicles contained within the multivesicular body (MVB) on the tegument of Echinostoma
caproni. Reproduced, with permission, from [56]. (B) Potential MVBs close to the tegumental surface of Schistosoma
mansoni cercariae, microvilli (m), tegument (t), spines (s), and multilaminate vesicles (mv) are noted. Reproduced, with
permission, from [57]. (C) Cross-section of Heligmosomoides polygyrus adult worms revealing numerous potential
extracellular vesicles (EVs) within the intestinal lumen. Reproduced, with permission, from [59]. (D) Anterior opening of
H. polygyrus covered in structures similar in size to exosomes, labeled as EVs.
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demonstrated that theH. polygyrus exosomes could suppress an inﬂammatory airway response
in vivo: during the ﬁrst 24 h of an innate atopic ‘danger’ response to the fungus Alternaria
alternata in vivo, H. polygyrus exosomes block activation of type 2 innate lymphoid cells and
have downstream effects on eosinophilic recruitment. Furthermore, H. polygyrus exosomes
suppressed expression of IL1RL1/ST2 (the IL-33-speciﬁc receptor subunit) following treatment
in vitro in intestinal epithelial cells and in vivo during the allergic asthma response to Alternaria. As
the IL-33 ligand–receptor interaction is known to be important in antihelminthic responses
[63,64], these data suggest the ability ofH. polygyrus exosomes tomodulate aspects of the host
cell response to prevent pathogen clearance. A previous report demonstrated that the model
free-living nematode Caenorhabditis elegans releases peptide-containing exosomes using a
deﬁned apical secretion pathway [65] and it is expected that exosomes may be used by all
nematodes, either as a mechanism of cell-to-cell communication within the organism or, when
exported outside the organism, as a mode of communication with other species.
In addition to the above reports, analyses of the secretion products of other helminths suggest
the presence of exosome-associated proteins, including CD63-like tetraspanins from the
cestode E. granulosus [66]. Tetraspanins have been implicated in the formation and targeting
of exosomes to recipient cells [67]. Interestingly, tetraspanins have independently been sug-
gested as promising targets for vaccination against another parasite, Echinococcus multi-
locularis, the causative agent of alveolar echinococcosis [67,68]. This suggests that
targeting exosomes and their surface proteinsmay provide an important antiparasite vaccination
strategy.
EVs from Microorganisms and Ectoparasites: More Players at the
Extracellular Surface
Other eukaryotes, such as the pathogenic fungus Paracoccidioides brasiliensis, release highly
immunogenic EVs that are detectable in the sera of paracoccidioidomycosis patients [69]. One
such immunogenic epitope is the cellular membrane carbohydrate galactose-/-1,3-galactose
(/-Gal), which is not found in human cells. Although /-Gal-enriched EVs may generate a robust
immune response in the host, they are suggested to be beneﬁcial to the pathogen, both bybinding
to host lectins and, potentially, by stimulating a suppressive type 2 response. This is in accordance
with previous literature showing that/-Gal-enriched T. cruzi exosomes are able to stimulate IL-4/
IL-10 expression in cardiac tissue and splenocytes [34]. Many types of opportunistic fungi,
including Cryptococcus neoformans, Candida albicans, and Histoplasma capsulatum, release
EVs [70], which have been suggested to contain virulence-associated factors including poly-
saccharides and lipids (reviewed further in [71]). The EVs released byC. neoformans, for example,
are enriched in virulent capsular components such as glucosylceramide and glucuronoxylo-
mannan (GXM) [72]. Interestingly, a recent study has shown the importance of phospholipid
translocases (ﬂippases) in C. neoformans exosome packaging and transport, whereby mutant
Apt1 ﬂippase-knockout fungi have diminished levels of GXM and are consequently unable to
successfully colonize the lung and brain of infected mice [73]. Furthermore, the yeastMalassezia
sympodialis, a component of natural human ﬂora, is able to release EVs capable of generating IL-4
and TNF secretion from peripheral bloodmononuclear cells, enhancing an inﬂammatory response
in patients afﬂictedwith atopic dermatitis [74]. Fungus-released EVsmay also induce antimicrobial
activity by host cells: EVs released by C. neoformans are taken up by macrophages in vitro and
stimulate TNF, IL-10, TGF-b, and nitric oxide production [75].
A recent study in the argasid tick, Ornithodoros moubata, suggests that some immunomodu-
latory proteins may be secreted in arthropod saliva, and it is tempting to speculate that EVs
would also be found in this environment. Proteomics of the tick saliva reveal several exosome-
associated proteins (e.g., aldolase, enolase) as well as anti-inﬂammatory lipocalins, which serve
as scavengers of leukotrienes, and adenosine nucleotides at the location of the bite [76]. It isTrends in Parasitology, October , Vol. 31, No. 10 485
clear that we are only at the beginning of many new discoveries with extracellular parasites and
the functionally diverse EVs they might secrete. There are a growing number of reports
containing proteomic matches to exosome proteins in parasite secretomes and this should
cement the idea that these are probably used bymost, or all, pathogens at some stage in their life
cycle. The effects that these EVs may exert at this interface will be of particular importance in the
context of antiparasite treatment, and conversely, based on the ability to suppress an innate
immune response [59], they may also be useful tools to ameliorate inﬂammation-associated
disease [4].
Host Exosomes in the Context of Pathogen Infection: A Useful Therapeutic
Strategy?
As parasites have evolved to secrete exosomes that are able to effectively interact with the host,
it is only logical that the host would also use this pathway as a defense mechanism. During
infection with a rodent malaria parasite, Plasmodium berghei, plasma cell-derived microvesicles
induce CD40 on antigen-presenting cells, generating a potent inﬂammatory response through
potential T cell priming and effector initiation [77]. Subsequently, macrophage activation may be
responsible for clearance of the parasite. This is further supported by studies in Plasmodium
vivax infection in humans, whereby immune cell-derived microvesicles are associated with
greater acute inﬂammation in the pursuit of parasite eradication [78]. These mechanisms
can be exploited in a therapeutic context; for example, murine reticulocytes infected with the
nonlethal Plasmodium yoelii X strain can signiﬁcantly attenuate pathogenesis when transferred
intomice that are then infectedwith the lethal strainP. yoelii XL [79]. On a separate note, intestinal
epithelial cells were shown to increase the release of antimicrobial peptide-containing exosomes
in response to Cryptosporidium infection, which is driven by enhanced toll-like receptor 4
signaling following recognition of the protozoan parasite [80]. The facultative intracellular bacte-
riumMycobacterium tuberculosis induces exosome release from infected macrophages, which
consequently promotes recruitment of lymphocytes through heightened inﬂammatory chemo-
kine secretion (such as RANTES and MIP-1/) [13,81]. Exosomes derived fromMycobacterium
bovis-infected macrophages are able to promote DC activation as well as generating an
antibacterial T cell response in vivo [82].
Host-derived exosomes also play important roles in antigen presentation. DCs pulsed with
Toxoplasma gondii antigens are able to induce both a systemic and a local humoral response
against the parasite in vivo, thereby serving as an efﬁcient vaccine against toxoplasmosis [83,84].
Similar results are seen in a vaccine trial with L. major-pulsed DC exosomes, showing that DC-
derived exosomes are able to mediate protective Th1 immunity against cutaneous leishmaniasis
in a cell-independent manner [85]. Importantly, several studies have emerged using DC-derived
exosomes for protection against common livestock parasites. Vaccination of chickens with
Eimeria parasite antigen-loaded DC exosomes was able to successfully ameliorate symptoms of
avian coccidiosis caused by several species (Eimeria tenella, Eimeria maxima, and Eimeria
acervulina) as well as reduce mortality rates [86].
Concluding Remarks and Future Perspectives
From this review, it is clear that exosomes and other EVs can be used by both parasite and host
to inﬂuence the outcome of an infection. Vesicles can function by transmitting signals between
parasites, from parasite to host, or from host to the environment for antigen presentation and
other aspects of host defense. The ability of vesicles to transport and deliver diverse populations
of molecules in a speciﬁc package might occupy a range of niches in biology. There has been a
surge of reports in the past 5 years detailing the presence of parasite-derived vesicles and it
seems likely that this will only increase with the appreciation that all organisms are likely to
secrete these [13]. Based on the literature, immune manipulation appears to be a prevalent486 Trends in Parasitology, October , Vol. 31, No. 10
Outstanding Questions
How are the diverse combinations of
molecules packaged into EVs inte-
grated in a functional response in recip-
ient cells?
Are all parasite EVs recognized by the
host immune system or are they able to
escape this?
How heterogeneous are the EVs
secreted by parasites and is it possible
that these have multiple targets and
functions?
How is EV packaging and release reg-
ulated and can this be targeted as a
therapeutic strategy?
What proteins are bound to the RNAs
within EVs and how would these inte-
grate into a functional RNAi pathway
inside recipient cells?function of parasite-derived exosomes, which feeds into numerous cell-to-cell interactions within
the human body [87]. However, it is expected that EVs could also play a prominent role in
parasite-to-parasite communication, which has been less well studied to date (see Outstanding
Questions Box). The molecules within exosomes that mediate their functions require further
investigation. We and others have detailed the small RNAs present in pathogen-derived
exosomes [59,88–91] and previous reports have shown the functionality of exosomal RNA
in an immune context [24,92,93]. One concern in this ﬁeld at present, however, is the lack of
quantitative data to determine the abundance and stoichiometry of RNA within EVs and whether
this is sufﬁcient for effective gene silencing under physiological conditions [94]. Intriguingly, we
found that an Argonaute protein is also secreted with exosomes derived from H. polygyrus, and
it could be expected that ribonucleoprotein complexes, rather than individual molecules, might
underpin functionality. In addition to nucleic acids, there aremany immunomodulatory proteins in
exosomes, [87,95–97], as well as lipids that might have immunomodulatory properties [98].
During the preparation of this manuscript, two additional papers demonstrated EV secretion by
helminths: the liver ﬂuke Opisthorchis viverrini [99] and pig whipworm Trichuris suis [100].
Chaiyadet et al. [99] show that EVs produced by O. viverrini drive IL-6 production and
proliferation of human cholangiocytes, and may link to the chronic periductal ﬁbrosis associated
with this pathogen. Additionally, they demonstrate that uptake of these EVs by host cells is
blocked by Ab directed against a surface tetraspanin. A deeper understanding of the biochemi-
cal properties of exosomes will be key to interrogating how these complicated packages of
information operate and how we can interfere with or mimic these processes to treat infectious
disease.
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